Kate Harnden, MBChB, discusses new study that identifies factors tied to disease persistence in patients with immune checkpoint inhibitor-induced arthritis and arthralgia.
Kate Harnden, MBChB
Advertisement
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds
Articles by Kate Harnden, MBChB
Joint Ventures: Lupus Health Inequalities, Growing Burden of ICI-Arthritis at EULAR 2026
Published: | Updated:
Sarah Dyball, MBBS, PhD, and Kate Harnden, MBChB, join hosts Rihards Buss, MD, to discuss their research at EULAR 2026.
Advertisement
Latest Updated Articles
Advertisement
Advertisement